{"DataElement":{"publicId":"3005447","version":"1","preferredName":"Graft Versus Host Disease Vulva Vaginal Symptoms Assessment Code","preferredDefinition":"Numeric code for vaginal or vulvar symptoms noted as part of the chronic Graft versus Host Disease (GVHD) Composite Assessment Scale evaluation tool, specifically the vaginal/vulvar component.","longName":"CGVHD_VUL_VAG_SX_CD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3005428","version":"1","preferredName":"Graft Versus Host Disease Vulva Vaginal Symptoms Assessment","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.__The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings._The final result of a determination of the value, significance, or extent of._The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia._Relating to the vagina or to any sheath._Subjective evidence of disease perceived by the patient.","longName":"GVHD_VUL_VAG_ASSM","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2512808","version":"1","preferredName":"Graft Versus Host Disease","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","longName":"C3063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89816F-5205-32C2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3005426","version":"1","preferredName":"Vulva Vaginal Symptom Assessment","preferredDefinition":"The external female genital organs, including the clitoris, vaginal lips, and the opening to the vagina.:Relating to the vagina or to any sheath.:An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.:The final result of a determination of the value, significance, or extent of.","longName":"C12408:C13309:C4876:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vulva","conceptCode":"C12408","definition":"The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Vaginal","conceptCode":"C13309","definition":"Of or relating to the vagina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D394-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D3A5-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3005433","version":"1","preferredName":"Chronic Graft Versus Host Disease Vulva Vaginal Symptom Code","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant and may affect multiple organs with manifestations similar to autoimmune diseases.  Onset is usually within three years of transplantation or immunologic manipulation._The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia._Relating to the vagina or to any sheath._Subjective evidence of disease perceived by the patient._A system of numbered categories for representation of data.","longName":"CGVHD_VUL_VAG_SX_CD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"9","valueDescription":"Vaginal synechiae including shortened vagina","ValueMeaning":{"publicId":"3005575","version":"1","preferredName":"Vaginal synechiae including shortened vagina","longName":"3005575","preferredDefinition":"Vaginal synechiae including shortened vagina","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EB583EB-7BD9-7A41-E040-BB89AD432550","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EB583EB-7BF2-7A41-E040-BB89AD432550","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"12","valueDescription":"Myofascial pain/spasm of levator or pelvic floor muscles","ValueMeaning":{"publicId":"3005434","version":"1","preferredName":"Myofascial pain/spasm of levator or pelvic floor muscles","longName":"3005434","preferredDefinition":"Myofascial pain/spasm of levator or pelvic floor muscles","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D3E0-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D3F9-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"11","valueDescription":"Introital stenosis","ValueMeaning":{"publicId":"3005435","version":"1","preferredName":"Introital stenosis","longName":"3005435","preferredDefinition":"Introital stenosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D403-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D41C-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"10","valueDescription":"Hematocolpos","ValueMeaning":{"publicId":"3005436","version":"1","preferredName":"Hematocolpos","longName":"3005436","preferredDefinition":"Hematocolpos","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D426-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D43F-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"8","valueDescription":"Vulvar architectural changes such as nearly complete resorption of the labia minora and clitoral agglutination","ValueMeaning":{"publicId":"3005438","version":"1","preferredName":"Vulvar architectural changes such as nearly complete resorption of the labia minora and clitoral agglutination","longName":"3005438","preferredDefinition":"Vulvar architectural changes such as nearly complete resorption of the labia minora and clitoral agglutination","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D46C-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D485-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"7","valueDescription":"Increased friability of vulvar mucosa","ValueMeaning":{"publicId":"3005439","version":"1","preferredName":"Increased friability of vulvar mucosa","longName":"3005439","preferredDefinition":"Increased friability of vulvar mucosa","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D48F-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D4A8-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"6","valueDescription":"Fissures in vulvar folds (e.g. interlabial sulci, fourchette)","ValueMeaning":{"publicId":"3005440","version":"1","preferredName":"Fissures in vulvar folds (e.g. interlabial sulci, fourchette)","longName":"3005440","preferredDefinition":"Fissures in vulvar folds (e.g. interlabial sulci, fourchette)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D4B2-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D4CB-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"5","valueDescription":"Erosions on flat surfaces, most notably on vulva","ValueMeaning":{"publicId":"3005441","version":"1","preferredName":"Erosions on flat surfaces, most notably on vulva","longName":"3005441","preferredDefinition":"Erosions on flat surfaces, most notably on vulva","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D4D5-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D4EE-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"4","valueDescription":"Leukokeratosis","ValueMeaning":{"publicId":"3005442","version":"1","preferredName":"Leukokeratosis","longName":"3005442","preferredDefinition":"Leukokeratosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D4F8-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D511-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"3","valueDescription":"Periurethral or other patchy erythema","ValueMeaning":{"publicId":"3005443","version":"1","preferredName":"Periurethral or other patchy erythema","longName":"3005443","preferredDefinition":"Periurethral or other patchy erythema","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D51B-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D534-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"2","valueDescription":"Generalized erythema/edema of vulva including vestibule","ValueMeaning":{"publicId":"3005444","version":"1","preferredName":"Generalized erythema/edema of vulva including vestibule","longName":"3005444","preferredDefinition":"Generalized erythema/edema of vulva including vestibule","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D53E-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D557-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"},{"value":"1","valueDescription":"Erythema around openings of vestibular glands","ValueMeaning":{"publicId":"3005445","version":"1","preferredName":"Erythema around openings of vestibular glands","longName":"3005445","preferredDefinition":"Erythema around openings of vestibular glands","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D561-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-D57A-328C-E040-BB89AD433B37","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3005432","version":"1","preferredName":"Chronic Graft Versus Host Disease Vulva Vaginal Symptom Code","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant and may affect multiple organs with manifestations similar to autoimmune diseases.  Onset is usually within three years of transplantation or immunologic manipulation.:The external female genital organs, including the clitoris, vaginal lips, and the opening to the vagina.:Relating to the vagina or to any sheath.:An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.:A system of numbered categories for representation of data.","longName":"C4981:C12408:C13309:C4876:C251","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Vulva","conceptCode":"C12408","definition":"The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Vaginal","conceptCode":"C13309","definition":"Of or relating to the vagina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D3BC-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D3CD-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2016-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Vulva or Vaginal Symptoms","type":"Preferred Question Text","description":"Vulva or Vaginal Symptoms","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-D584-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeDescription":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}